InveniAI LLC has launched a new subsidiary, AlphaMeld Corporation, aimed at enhancing drug discovery through AI-driven technology. The initiative includes advancements in small molecule design and biologics design capabilities, among other milestones.
Company Information
Company
InveniAI
Location
Connecticut, United States
About
AlphaMeld Corporation, a wholly owned subsidiary of InveniAI LLC, is a global frontrunner in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools in drug discovery and development. The company aims to identify and accelerate transformative therapies for diseases with unmet medical needs. Its innovative platforms foster the creation of groundbreaking drug programs by analyzing extensive data sets. AlphaMeld Corporation stands at the cutting edge of innovation in the biopharmaceutical sector.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment InveniAI ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.